Karyn M. Frick
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Karyn M. Frick has a total of 186 co-authors. Here are the top co-authors by number of shared publications:
Ashley M. Fortress
Department of Psychology, University of Wisconsin-Milwaukee, Milwaukee, WI 53211, United States
12 shared publications- Jaekyoon Kim
Department of Neuroscience and Pharmacology, Carver College of Medicine, University of Iowa
10 shared publications - Jennifer J. Tuscher
Department of Neurobiology, University of Alabama at Birmingham
9 shared publications Patrick T. Orr
Department of Psychology, Yale University, New Haven, Connecticut 06520, USA
7 shared publicationsJodi E. Gresack
6 shared publicationsLu Fan
Department of Psychology, Yale University, New Haven, Connecticut 06520, USA
6 shared publications
Latest Publications
- 9 October 2026
- Published by Society for Neuroscience in The Journal of Neuroscience
- Vol. 46 (44)
Estradiol-Dependent Memory and Hippocampal Spine Remodeling Require Proteasomal Protein Degradation
Although 17β-estradiol (E 2 ) is a critical neuromodulator of hippocampus-dependent memory and synaptic plasticity, the molecular mechanisms underlying these effects remain incompletely understood. Previous studies showed that E 2 enhances dorsal hippocampus (DH)-dependent memory consolidation by activating signaling pathways that promote protein synthesis and dendritic spine formation. However, these studies largely overlooked the contribution of protein degradation mediated by the ubiquitin proteasome system (UPS), despite extensive evidence implicating UPS activity in long-term memory and synaptic plasticity. Here, we combined temporally specific dorsal hippocampal infusions of the proteasome inhibitor β-lactone with three-dimensional spine morphometry to examine the role of UPS-mediated protein degradation in E 2 -induced memory consolidation and CA1 spinogenesis. Immediate post-training bilateral infusion of β-lactone into the DH of ovariectomized female mice blocked E 2 -induced enhancement of object recognition memory and attenuated E 2 -associated improvements in spatial memory. Arbor-wide Golgi-based analyses revealed robust E 2 -induced increases in spine number across the apical dendritic tree and smaller parallel effects within the basal arbor. Segment-level analyses showed that E 2 produced the greatest structural changes on tertiary apical dendritic segments, increasing total, mushroom, and thin spine density and enhancing multiple morphometric features, including mushroom spine surface area and head-to-neck ratio. Secondary basal dendritic segments exhibited smaller, more variable changes. Many E 2 -associated structural effects were attenuated or abolished by β-lactone. Together, these findings provide the first evidence that proteasomal protein degradation contributes to estrogenic enhancement of hippocampus-dependent memory and CA1 dendritic spine remodeling, identifying UPS-mediated protein degradation as a previously unrecognized mechanism regulating estrogenic memory consolidation and structural plasticity.
- 9 October 2026
- Published by Society for Neuroscience in The Journal of Neuroscience
- Vol. 46 (44)
Estradiol-Dependent Memory and Hippocampal Spine Remodeling Require Proteasomal Protein Degradation
Although 17β-estradiol (E 2 ) is a critical neuromodulator of hippocampus-dependent memory and synaptic plasticity, the molecular mechanisms underlying these effects remain incompletely understood. Previous studies showed that E 2 enhances dorsal hippocampus (DH)-dependent memory consolidation by activating signaling pathways that promote protein synthesis and dendritic spine formation. However, these studies largely overlooked the contribution of protein degradation mediated by the ubiquitin proteasome system (UPS), despite extensive evidence implicating UPS activity in long-term memory and synaptic plasticity. Here, we combined temporally specific dorsal hippocampal infusions of the proteasome inhibitor β-lactone with three-dimensional spine morphometry to examine the role of UPS-mediated protein degradation in E 2 -induced memory consolidation and CA1 spinogenesis. Immediate post-training bilateral infusion of β-lactone into the DH of ovariectomized female mice blocked E 2 -induced enhancement of object recognition memory and attenuated E 2 -associated improvements in spatial memory. Arbor-wide Golgi-based analyses revealed robust E 2 -induced increases in spine number across the apical dendritic tree and smaller parallel effects within the basal arbor. Segment-level analyses showed that E 2 produced the greatest structural changes on tertiary apical dendritic segments, increasing total, mushroom, and thin spine density and enhancing multiple morphometric features, including mushroom spine surface area and head-to-neck ratio. Secondary basal dendritic segments exhibited smaller, more variable changes. Many E 2 -associated structural effects were attenuated or abolished by β-lactone. Together, these findings provide the first evidence that proteasomal protein degradation contributes to estrogenic enhancement of hippocampus-dependent memory and CA1 dendritic spine remodeling, identifying UPS-mediated protein degradation as a previously unrecognized mechanism regulating estrogenic memory consolidation and structural plasticity.
- Open Access
- 5 June 2025
- Published by Elsevier in Hormones and Behavior
- Vol. 173, 105773
Not your mother's hormone therapy: Highly selective estrogen receptor beta agonists as next-generation therapies for menopausal symptom relief
- 5 June 2025
- Published by Elsevier in Hormones and Behavior
- Vol. 173, 105773
Open AccessNot your mother's hormone therapy: Highly selective estrogen receptor beta agonists as next-generation therapies for menopausal symptom relief
- Open Access
- 13 November 2024
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 16, 1477045
The novel estrogen receptor beta agonist EGX358 and APOE genotype influence memory, vasomotor, and anxiety outcomes in an Alzheimer’s mouse model
Introduction: Alzheimer’s disease (AD) prevalence and severity are associated with increased age, female sex, and apolipoprotein E4 (APOE4) genotype. Although estrogen therapy (ET) effectively reduces symptoms of menopause including hot flashes and anxiety, and can reduce dementia risk, it is associated with increased risks of breast and uterine cancer due to estrogen receptor alpha (ERα)-mediated increases in cancer cell proliferation. Because ERβ activation reduces this cell proliferation, selective targeting of ERβ may provide a safer method of improving memory and reducing hot flashes in menopausal women, including those with AD. APOE genotype influences the response to ET, although it is unknown whether effects of ERβ activation vary by genotype.Methods: Here, we tested the ability of long-term oral treatment with a novel highly selective ERβ agonist, EGX358, to enhance object recognition and spatial recognition memory, reduce drug-induced hot flashes, and influence anxiety-like behaviors in female mice expressing 5 familial AD mutations (5xFAD-Tg) and human APOE3 (E3FAD) or APOE3 and APOE4 (E3/4FAD). Mice were ovariectomized at 5 months of age and were then treated orally with vehicle (DMSO) or EGX358 (10 mg/kg/day) via hydrogel for 8 weeks. Spatial and object recognition memory were tested in object placement (OP) and object recognition (OR) tasks, respectively, and anxiety-like behaviors were tested in the open field (OF) and elevated plus maze (EPM). Hot flash-like symptoms (change in tail skin temperature) were measured following injection of the neurokinin receptor agonist senktide (0.5 mg/kg).Results: EGX358 enhanced object recognition memory in E3FAD and E3/4FAD mice but did not affect spatial recognition memory. EGX358 also reduced senktide-induced tail temperature elevations in E3FAD, but not E3/4FAD, females. EGX358 did not influence anxiety-like behaviors or body weight.Discussion: These data indicate that highly selective ERβ agonism can facilitate object recognition memory in both APOE3 homozygotes and APOE3/4 heterozygotes, but only reduce the magnitude of a drug-induced hot flash in APOE3 homozygotes, suggesting that APOE4 genotype may blunt the beneficial effects of ET on hot flashes. Collectively, these data suggest a potentially beneficial effect of selective ERβ agonism for memory and hot flashes in females with AD-like pathology, but that APOE genotype plays an important role in responsiveness.
- 13 November 2024
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 16, 1477045
Open AccessThe novel estrogen receptor beta agonist EGX358 and APOE genotype influence memory, vasomotor, and anxiety outcomes in an Alzheimer’s mouse model
Introduction: Alzheimer’s disease (AD) prevalence and severity are associated with increased age, female sex, and apolipoprotein E4 (APOE4) genotype. Although estrogen therapy (ET) effectively reduces symptoms of menopause including hot flashes and anxiety, and can reduce dementia risk, it is associated with increased risks of breast and uterine cancer due to estrogen receptor alpha (ERα)-mediated increases in cancer cell proliferation. Because ERβ activation reduces this cell proliferation, selective targeting of ERβ may provide a safer method of improving memory and reducing hot flashes in menopausal women, including those with AD. APOE genotype influences the response to ET, although it is unknown whether effects of ERβ activation vary by genotype.Methods: Here, we tested the ability of long-term oral treatment with a novel highly selective ERβ agonist, EGX358, to enhance object recognition and spatial recognition memory, reduce drug-induced hot flashes, and influence anxiety-like behaviors in female mice expressing 5 familial AD mutations (5xFAD-Tg) and human APOE3 (E3FAD) or APOE3 and APOE4 (E3/4FAD). Mice were ovariectomized at 5 months of age and were then treated orally with vehicle (DMSO) or EGX358 (10 mg/kg/day) via hydrogel for 8 weeks. Spatial and object recognition memory were tested in object placement (OP) and object recognition (OR) tasks, respectively, and anxiety-like behaviors were tested in the open field (OF) and elevated plus maze (EPM). Hot flash-like symptoms (change in tail skin temperature) were measured following injection of the neurokinin receptor agonist senktide (0.5 mg/kg).Results: EGX358 enhanced object recognition memory in E3FAD and E3/4FAD mice but did not affect spatial recognition memory. EGX358 also reduced senktide-induced tail temperature elevations in E3FAD, but not E3/4FAD, females. EGX358 did not influence anxiety-like behaviors or body weight.Discussion: These data indicate that highly selective ERβ agonism can facilitate object recognition memory in both APOE3 homozygotes and APOE3/4 heterozygotes, but only reduce the magnitude of a drug-induced hot flash in APOE3 homozygotes, suggesting that APOE4 genotype may blunt the beneficial effects of ET on hot flashes. Collectively, these data suggest a potentially beneficial effect of selective ERβ agonism for memory and hot flashes in females with AD-like pathology, but that APOE genotype plays an important role in responsiveness.
- Open Access
- 23 August 2024
- Published by Elsevier in Hormones and Behavior
- Vol. 165, 105618
Astrocytic glutamate transport is essential for the memory-enhancing effects of 17β-estradiol in ovariectomized mice
- 23 August 2024
- Published by Elsevier in Hormones and Behavior
- Vol. 165, 105618
Open AccessAstrocytic glutamate transport is essential for the memory-enhancing effects of 17β-estradiol in ovariectomized mice
- Open Access
- 29 February 2024
- Published by Elsevier in Hormones and Behavior
- Vol. 161, 105516
G protein-coupled estrogen receptor (GPER) in the dorsal hippocampus regulates memory consolidation in gonadectomized male mice, likely via different signaling mechanisms than in female mice
- 29 February 2024
- Published by Elsevier in Hormones and Behavior
- Vol. 161, 105516
Open AccessG protein-coupled estrogen receptor (GPER) in the dorsal hippocampus regulates memory consolidation in gonadectomized male mice, likely via different signaling mechanisms than in female mice
- 25 July 2023
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 34 (9) , 526-538
New perspectives on sex differences in learning and memory
- 25 July 2023
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 34 (9) , 526-538
New perspectives on sex differences in learning and memory
- Open Access
- 2 September 2022
- Published by Cold Spring Harbor Laboratory in Learning & Memory
- Vol. 29 (9) , 302-311
Sex differences in training-induced activity of the ubiquitin proteasome system in the dorsal hippocampus and medial prefrontal cortex of male and female mice
The ubiquitin proteasome system (UPS) is a primary mechanism through which proteins are degraded in cells. UPS activity in the dorsal hippocampus (DH) is necessary for multiple types of memory, including object memory, in male rodents. However, sex differences in DH UPS activation after fear conditioning suggest that other forms of learning may also differentially regulate DH UPS activity in males and females. Here, we examined markers of UPS activity in the synaptic and cytoplasmic fractions of DH and medial prefrontal cortex (mPFC) tissue collected 1 h following object training. In males, training increased phosphorylation of proteasomal subunit Rpt6, 20S proteasome activity, and the amount of PSD-95 in the DH synaptic fraction, as well as proteasome activity in the mPFC synaptic fraction. In females, training did not affect measures of UPS or synaptic activity in the DH synaptic fraction or in either mPFC fraction but increased Rpt6 phosphorylation in the DH cytoplasmic fraction. Overall, training-induced UPS activity was greater in males than in females, greater in the DH than in the mPFC, and greater in synaptic fractions than in cytosol. These data suggest that object training drives sex-specific alterations in UPS activity across brain regions and subcellular compartments important for memory.
- 2 September 2022
- Published by Cold Spring Harbor Laboratory in Learning & Memory
- Vol. 29 (9) , 302-311
Open AccessSex differences in training-induced activity of the ubiquitin proteasome system in the dorsal hippocampus and medial prefrontal cortex of male and female mice
The ubiquitin proteasome system (UPS) is a primary mechanism through which proteins are degraded in cells. UPS activity in the dorsal hippocampus (DH) is necessary for multiple types of memory, including object memory, in male rodents. However, sex differences in DH UPS activation after fear conditioning suggest that other forms of learning may also differentially regulate DH UPS activity in males and females. Here, we examined markers of UPS activity in the synaptic and cytoplasmic fractions of DH and medial prefrontal cortex (mPFC) tissue collected 1 h following object training. In males, training increased phosphorylation of proteasomal subunit Rpt6, 20S proteasome activity, and the amount of PSD-95 in the DH synaptic fraction, as well as proteasome activity in the mPFC synaptic fraction. In females, training did not affect measures of UPS or synaptic activity in the DH synaptic fraction or in either mPFC fraction but increased Rpt6 phosphorylation in the DH cytoplasmic fraction. Overall, training-induced UPS activity was greater in males than in females, greater in the DH than in the mPFC, and greater in synaptic fractions than in cytosol. These data suggest that object training drives sex-specific alterations in UPS activity across brain regions and subcellular compartments important for memory.
- 21 April 2022
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 141, 105773
Extracellular matrix metalloproteinase-9 (MMP-9) is required in female mice for 17β-estradiol enhancement of hippocampal memory consolidation
- 21 April 2022
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 141, 105773
Extracellular matrix metalloproteinase-9 (MMP-9) is required in female mice for 17β-estradiol enhancement of hippocampal memory consolidation
- 8 February 2022
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 65 (4) , 3388-3403
Development of a Novel, Small-Molecule Brain-Penetrant Histone Deacetylase Inhibitor That Enhances Spatial Memory Formation in Mice
Histone acetylation is a prominent epigenetic modification linked to the memory loss symptoms associated with neurodegenerative disease. The use of existing histone deacetylase inhibitor (HDACi) drugs for treatment is precluded by their weak blood–brain barrier (BBB) permeability and undesirable toxicity. Here, we address these shortcomings by developing a new class of disulfide-based compounds, inspired by the scaffold of the FDA-approved HDACi romidepsin (FK288). Our findings indicate that our novel compound MJM-1 increases the overall level of histone 3 (H3) acetylation in a prostate cancer cell line. In mice, MJM-1 injected intraperitoneally (i.p.) crossed the BBB and could be detected in the hippocampus, a brain region that mediates memory. Consistent with this finding, we found that the post-training i.p. administration of MJM-1 enhanced hippocampus-dependent spatial memory consolidation in male mice. Therefore, MJM-1 represents a potential lead for further optimization as a therapeutic strategy for ameliorating cognitive deficits in aging and neurodegenerative diseases.
- 8 February 2022
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 65 (4) , 3388-3403
Development of a Novel, Small-Molecule Brain-Penetrant Histone Deacetylase Inhibitor That Enhances Spatial Memory Formation in Mice
Histone acetylation is a prominent epigenetic modification linked to the memory loss symptoms associated with neurodegenerative disease. The use of existing histone deacetylase inhibitor (HDACi) drugs for treatment is precluded by their weak blood–brain barrier (BBB) permeability and undesirable toxicity. Here, we address these shortcomings by developing a new class of disulfide-based compounds, inspired by the scaffold of the FDA-approved HDACi romidepsin (FK288). Our findings indicate that our novel compound MJM-1 increases the overall level of histone 3 (H3) acetylation in a prostate cancer cell line. In mice, MJM-1 injected intraperitoneally (i.p.) crossed the BBB and could be detected in the hippocampus, a brain region that mediates memory. Consistent with this finding, we found that the post-training i.p. administration of MJM-1 enhanced hippocampus-dependent spatial memory consolidation in male mice. Therefore, MJM-1 represents a potential lead for further optimization as a therapeutic strategy for ameliorating cognitive deficits in aging and neurodegenerative diseases.